Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs
- PMID: 9890660
Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs
Abstract
Drug resistance is a prominent problem of cancer therapy. Differences in quantity and quality of many metabolites in normal and malignant cells and their changes after treatment by anticancer drugs can be detected by nuclear magnetic resonance (NMR) both in vivo and in vitro. The results of in vivo and in vitro 1H, 13C, 19F and 31P NMR spectroscopy and their correlation with the degree of resistance to anticancer drugs are discussed. Monitoring of treatment and development of drug resistance by this non-invasive method could be useful not only in cancer research related to drug resistance but also in clinical medical oncology.
Similar articles
-
Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review.Cancer Res. 1989 Feb 15;49(4):770-9. Cancer Res. 1989. PMID: 2643462 Review.
-
An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principle.Clin Cancer Res. 2005 Feb 15;11(4):1454-61. doi: 10.1158/1078-0432.CCR-04-1439. Clin Cancer Res. 2005. PMID: 15746046
-
Magnetic resonance spectroscopy applied to clinical oncology.Technol Health Care. 1994 Dec;2(4):235-46. Technol Health Care. 1994. PMID: 7842308 Review.
-
Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.Cancer Res. 2001 Oct 15;61(20):7536-43. Cancer Res. 2001. PMID: 11606391
-
Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.Cancer Res. 1990 Feb 1;50(3):544-51. Cancer Res. 1990. PMID: 2297696